China Cord Blood Corp Revenue, Profits - CO Quarterly Income Statement

Add to My Stocks
$12.54 $0.5 (3.83%) CO stock closing price Aug 17, 2017 (Closing)

Fundamental analysis of CO stock involves analyzing its financial statements, apart from checking the China Cord Blood Corp stock price An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement is generated for a specific period of time. The revenue increase of $29.35M for 2017-Q4 impacts the CO stock. Investors typically check year over year or quarter over quarter revenue growth. The China Cord Blood Corp profit and loss statement for 2017-Q4 shows a profit of $5.51M. Profits have reduced from $8.05M QoQ. Apart from this an investor should also check China Cord Blood Corp assets and China Cord Blood Corp free cash flow. View details of revenue and profits for China Cord Blood Corp for latest & last 40 quarters.

show more
View Previous Quarters
View Next Quarters
Fiscal year is Apr - Mar.2017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
China Cord Blood Corp Net Sales or Revenues
Cost Of Goods Sold (COGS)5.62M3.61M5.86M5.63M5.1M5.58M5.85M5.89M5.52M5.81M
China Cord Blood Corp Gross Profit
Research & Development Expense0.45M0.41M0.35M0.29M0.35M0.4M0.33M0.31M0.42M0.39M
Selling General & Admin Expense14.02M10.25M13.18M12.25M11.85M12.32M12.52M12.64M12.25M9.72M
Income Before Depreciation Depletion Amortization7.8M14.64M8.2M7.84M5.78M7.83M8.25M7.81M7.92M10.93M
Depreciation Depletion Amortization----------
Non Operating Income1.29M0.31M0.75M0.68M0.75M6.41M0.87M0.95M0.77M0.81M
Interest Expense4.15M4.4M4.46M4.33M4.15M4.29M4.13M4.17M4.04M4.15M
China Cord Blood Corp Pretax Income
Provision for Income Taxes-0.65M2.47M1.89M1.75M1.23M2.1M2.01M2.41M1.88M2.17M
Minority Interest0.18M0.02M0.09M0.07M-0.03M0.06M0.03M-0.01M0.07M0.03M
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations5.51M8.05M2.5M2.37M1.28M7.79M2.95M2.19M2.73M5.38M
Extraordinary Items & Discontinued Operations----------
China Cord Blood Corp Net Income (Profit/Loss)
Average Shares used to compute Diluted EPS78.73M80.49M83.2M78.9M73M73.14M73.65M72.83M68.23M76.86M
Average Shares used to compute Basic EPS78.73M80.49M83.2M78.9M73M73.14M73.65M72.83M68.23M76.86M
Income Before Nonrecurring Items5.51M8.05M2.5M2.37M1.28M7.79M3.8M2.19M2.73M5.38M
Income from Nonrecurring Items-------0.86M---
China Cord Blood Corp Earnings Per Share Basic Net
China Cord Blood Corp Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items0.
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

It is very helpful to read a report on China Cord Blood Corp stock analysis. An investor must check the following items in an income statement:
  • Revenue: This is the inflow that is generated from the sale of goods or services and is $29.35M for this quarter of 2017-Q4. Our China Cord Blood Corp revenue chart gives a clear visual representation of how the topline growth has been. Investors often invest in only those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $5.51M for China Cord Blood Corp for 2017-Q4. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.
The income statement is also called statement of revenue and expense. The financials along with China Cord Blood Corp historical stock prices provides a lot of details about the firm. .

China Cord Blood Corp Income Statement - Key Financial Ratios

PE ratio (price earnings ratio)
PS ratio (
price sales ratio
Operating margin
Net profit margin
Dividend yield

Other Income Statements - China Cord Blood Corp Industry Peers

Cryo Cell International income statement, LHC income statement, Pharmerica income statement